US Patent 7390907 Vanilloid receptor ligands and their use in treatments
Patent 7390907 was granted and assigned to Amgen on June, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+53 characters)
Article
Patent abstract
Compounds having the general structure
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07390907 Vanilloid receptor ligands and their use in treatments US Patent 7390907 Vanilloid receptor ligands and their use in treatments
Infobox
Patent Number
0739090700
Patent Number
739090700
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073909070
Date of Patent
June 24, 2008
0Patent Application Number
109566480
Date Filed
September 30, 2004
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073909070
Date of Patent
June 24, 2008
0Patent Application Number
109566480
Date Filed
September 30, 2004
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07390907 Vanilloid receptor ligands and their use in treatments
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07390907
Date of patent
June 24, 2008
Patent application number
10956648
Date Filed
September 30, 2004
Patent primary examiner
Find more entities like US Patent 7390907 Vanilloid receptor ligands and their use in treatments
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
